Skip to main content
icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

$33,967 Vol.

2026/12/30
Polymarket

$33,967 Vol.

Polymarket

South Sudan

$2,058 Vol.

66%

Rwanda

$2,128 Vol.

27%

Burundi

$200 Vol.

31%

United States

$10,195 Vol.

23%

Canada

$1,086 Vol.

29%

Kenya

$195 Vol.

54%

India

$732 Vol.

14%

Republic of the Congo

$12,150 Vol.

24%

Nigeria

$25 Vol.

53%

Ethiopia

$65 Vol.

52%

Somalia

$71 Vol.

24%

China

$3,108 Vol.

18%

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The rapid escalation of the Bundibugyo strain outbreak in the Democratic Republic of the Congo since its May 2026 declaration has defined trader sentiment, with cases surging past 5,200 and deaths exceeding 2,400 by mid-August amid conflict-driven mobility and the absence of an approved vaccine. This has locked in DRC while highlighting containment successes elsewhere, such as Uganda declaring its linked outbreak over in late July after rigorous tracing and no local transmission since June. Imported cases reached France and prompted treatment in Germany, but sustained spread has stayed limited, keeping regional neighbors on alert without confirmed new chains. Traders watch for border developments, response funding gaps, and any late-year spillover into additional African nations as the dominant swing factors through year-end.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
音量
$33,967
終了日
2026/12/31
マーケット開始日
May 22, 2026, 12:35 PM ET
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The rapid escalation of the Bundibugyo strain outbreak in the Democratic Republic of the Congo since its May 2026 declaration has defined trader sentiment, with cases surging past 5,200 and deaths exceeding 2,400 by mid-August amid conflict-driven mobility and the absence of an approved vaccine. This has locked in DRC while highlighting containment successes elsewhere, such as Uganda declaring its linked outbreak over in late July after rigorous tracing and no local transmission since June. Imported cases reached France and prompted treatment in Germany, but sustained spread has stayed limited, keeping regional neighbors on alert without confirmed new chains. Traders watch for border developments, response funding gaps, and any late-year spillover into additional African nations as the dominant swing factors through year-end.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
音量
$33,967
終了日
2026/12/31
マーケット開始日
May 22, 2026, 12:35 PM ET
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.

外部リンクに注意してください。

よくある質問

「Which countries will have an Ebola case in 2026?」はPolymarket上の13個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「Uganda」で100%、次いで「South Sudan」が66%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、100¢で取引されているシェアは、市場がその結果に100%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

本日現在、「Which countries will have an Ebola case in 2026?」は$34Kの総取引量を生み出しています(May 22, 2026のマーケット開始以来)。この取引活動レベルはPolymarketコミュニティの強い関与を反映し、現在のオッズが幅広い市場参加者によって形成されていることを保証します。このページで直接、ライブの価格変動を追跡し、任意の結果で取引できます。

「Which countries will have an Ebola case in 2026?」で取引するには、このページに記載されている13個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

「Which countries will have an Ebola case in 2026?」の現在のフロントランナーは「Uganda」で100%であり、市場がこの結果に100%の確率を割り当てていることを意味します。次に近い結果は「South Sudan」で66%です。これらのオッズはトレーダーがシェアを売買するにつれてリアルタイムで更新されます。頻繁に確認するか、このページをブックマークしてください。

「Which countries will have an Ebola case in 2026?」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。